X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/05/2858708/0/en/Araris-Biotech-AG-Presents-Data-on-Novel-Antibody-Drug-Conjugates-at-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2024/03/06/2841357/0/en/Araris-Biotech-AG-to-Present-Data-on-Antibody-Drug-Conjugate-Candidates-at-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2023/11/08/2775818/0/en/Araris-Biotech-AG-Announces-Research-Collaboration-with-Taiho-Pharmaceutical-to-Develop-Next-Generation-ADCs-Using-Araris-Proprietary-Linker-Conjugation-Technology.html
https://www.globenewswire.com//news-release/2023/10/04/2754510/0/en/Araris-Biotech-AG-Initiates-Leadership-Transition-to-Advance-Next-Evolution-of-Growth-in-its-Antibody-Drug-Conjugate-ADC-Pipeline.html
https://www.globenewswire.com/news-release/2023/05/05/2662277/0/en/Araris-Biotech-AG-Supported-with-CHF-2-5M-Swiss-Accelerator-Grant-from-Innosuisse-to-Develop-Antibody-Drug-Conjugate-Candidates.html
https://www.globenewswire.com/news-release/2023/04/17/2648116/0/en/Araris-Biotech-AG-Acquires-ARS-Pharmaceutical-s-Nectin-4-Antibody.html
https://www.globenewswire.com/news-release/2023/04/14/2647251/0/en/Araris-Biotech-AG-Presents-Preclinical-Data-Highlighting-Stable-and-Efficacious-Low-Drug-Load-ADCs-at-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2023.html
https://www.globenewswire.com/news-release/2023/04/12/2645027/0/en/Araris-Biotech-AG-Announces-Strategic-Investment-with-Samsung-Ventures.html
https://www.globenewswire.com/news-release/2023/03/14/2627234/0/en/Araris-Biotech-AG-to-Present-Preclinical-Data-at-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2023.html
Market Place
Share 
